Algo version: 0.98b
Tianjin Pharmaceutical Da is listed at the SHH Exchange
Tianjin Pharmaceutical Da [600329.SS]
SHH Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is Tianjin Pharmaceutical Da stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Tianjin Pharmaceutical Da pays dividends. Last time was Friday 12th of July 2024 where the investors holding the stock on Friday 12th of July 2024 were paid CNY1.28 per share. Over the last 20 times between 2002 and 2024, Tianjin Pharmaceutical Da has paid CNY5.7418 with an average of CNY0.29 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Tianjin Pharmaceutical Da 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was CNY14.73, you would have made a profit of CNY13.24 per share or 89.88%

Yes, the average daily trading liquidity for Tianjin Pharmaceutical Da is CNY4.85 million. You should therefore be able to get in and out of your positions relatively fast.

Tianjin Pharmaceutical Da has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.52, the company's ability to pay off the debt is good. Tianjin Pharmaceutical Da has a good net profit margin of 12.01% and should have high tolerances against inflation.

We have calculated the inflation risk for Tianjin Pharmaceutical Da to be low [0.25 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.